Mersana Therapeutics to Host Third Quarter 2022 Conference Call on November 7, 2022
CAMBRIDGE, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused…
1,678€
-4,50%
Echtzeit-Aktienkurs Mersana Therapeutics
Bid:
Ask:
Nachrichten zur Mersana Therapeutics Aktie
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on…